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Abstract 
Background: Human protein kinase CK2 represents a novel therapeutic target for neoplastic diseases. Inhibitors are 
in need to explore the druggability and the therapeutic options of this enzyme. A bottleneck in the search for new 
inhibitors is the availability of the target for testing. Therefore an assay was developed to provide easy access to CK2 
for discovery of novel inhibitors.
Results: Autodisplay was used to present human CK2 on the surface of Escherichia coli. Heterotetrameric CK2 con-
sists of two subunits, α and β, which were displayed individually on the surface. Co-display of CK2α and CK2β on the 
cell surface led to the formation of functional holoenzyme, as demonstrated by NaCl dependency of enzymatic activ-
ity, which differs from that of the catalytic subunit CK2α without β. In addition interaction of CK2α and CK2β at the cell 
surface was confirmed by co-immunoprecipitation assays. Surface displayed CK2 holoenzyme enabled an easy IC50 
value determination. The IC50 values for the known CK2 inhibitors TBB and Silmitasertib were determined to be 50 and 
3.3 nM, respectively.
Conclusion: Surface-displayed CK2α and CK2β assembled on the cell surface of E. coli to an active tetrameric holoen-
zyme. The whole-cell CK2 autodisplay assay as developed is suitable for inhibition studies. Furthermore, it can be used 
to determine quantitative CK2 inhibition data such as IC50 values. In summary, this is the first report on the functional 
surface display of a heterotetrameric enzyme on E. coli.
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Background
To display a functional protein on the surface of a living 
cell bears several advantages in comparison to intracellu-
lar expression [1]. The protein at the cell surface is freely 
accessible for any kind of binding or activity studies. This 
can be applied e.g. in assays that allow to quantify protein–
protein interactions by displaying one partner protein at 
the cell surface and subsequently add the binding part-
ner protein labeled with a fluorescent dye, and determine 
the interaction by quantifying the whole cell fluorescence 
obtained thereby with the help of flow cytometry [2]. 
The screening of antibody libraries can be performed in 
a similar way, when the variants are displayed on the cell 
surface. The labeled antigen can be used, binding can be 
quantified by flow cytometry, and finally single cells bear-
ing a distinct variant can be selected by fluorescence acti-
vated cell sorting [3, 4]. Such strategy can also be applied 
to identify novel enzyme inhibitors, taking into account 
that inhibitors have a high affinity (or a low dissociation 
constant) for enzymes they are inhibiting. In such case, 
peptide libraries displayed on the surface of E. coli can 
be screened by fluorescence labeled target enzymes, 
and whole cell fluorescence can be used for selecting 
strong binding variants [5, 6]. At this point it needs to be 
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emphasized, that the libraries actually consist of different 
cells of E. coli, each displaying a different variant. Moreo-
ver one needs to have in mind that binding does not nec-
essarily mean inhibition of the enzyme, but subsequently 
the selected variants can be tested on enzyme inhibition, 
and proofed to be a reliable source for novel inhibitors. 
Beside these activa for screening purposes, the cellular 
surface display of a protein, namely an enzyme has also 
advantages in the development of whole cell biocatalysts 
[7]. Neither the substrate nor the product need to cross 
a membrane barrier, and the formation of by-products by 
other enzymes is prevented, as it could appear by whole 
cell biocatalysts with intracellular enzyme expression. 
This is in particular an issue in the biocatalytic production 
of pharmaceuticals. Moreover, being anchored at the cell 
surface increases enzymatic stability [8], and in case the 
enzyme needs a membrane environment to be active this 
can be provided as well [9, 10]. A disadvantage of whole 
cell biocatalysts with surface displayed enzymes is, how-
ever, that enzymes which need supply of co-factors, e.g. 
redox co-factors like NADH or NAD+, are excluded from 
the regeneration circles, as available in the cytoplasm. For 
many of the applications mentioned here, autodisplay 
has been proven to be a helpful tool. In principle, auto-
display is the surface display of a recombinant protein in 
a Gram-negative bacterium by means of the autotrans-
porter secretion pathway [11–13]. Nevertheless, most of 
the applications described until now are for the AIDA-I 
autotransporter to display a recombinant protein on 
E. coli [1]. One advantage of using the AIDA-I autotrans-
porter for surface display in E. coli is the high number 
of displayed proteins, which were reported to be in the 
range of 105–106 [14, 15]. A second advantage is, that the 
anchoring domain, the so-called β-barrel, is not covalently 
linked to the surface, but can move or “swim” within the 
plane of the outer membrane. This can lead to a passenger 
driven dimerization or even multimerization at the cell 
surface, by simple expression and surface display of the 
corresponding monomer [16]. More recently it has been 
sown, that the co-display of a lipase and its specific fol-
dase by AIDA-I leads to an active lipase biocatalyst [17]. 
This takes again benefit from the motility of the anchor-
ing domains, allowing the lipase and the foldase to get 
into direct contact at the cell surface. In the present study 
we displayed human protein kinase CK2 by autodisplay 
on the surface of E. coli. Human protein kinase CK2 is an 
emerging target for cancer diseases [18, 19]. Despite two 
inhibitors of the enzymes are in clinical trials phase II at 
current [20, 21] more inhibitors are in need to explore the 
druggability and the therapeutic options of human CK2 
[22]. A bottleneck in the search for new inhibitors is the 
availability of the target, i.e. human protein kinase CK2 
for testing. Protein kinase CK2 is a heterotetramer, con-
sisting of two subunits, a catalytic α-subunit (which can 
be replaced in some case by an αʹ-subunit) and a so-called 
regulatory β-subunit. We expressed and displayed the α- 
and the β-subunit of human CK2 separately on the sur-
face of E. coli and showed the formation of the tetrameric 
holoenzyme by measuring an increased kinase activity in 
comparison to the α-subunit being displayed alone, by 
activity profiling using varying NaCl concentrations, and 
by co-immunoprecipitation experiments. Cells of E. coli 
displaying the holoenzyme could be used to determine 
the inhibition constants of two established CK2 inhibi-
tors. Our results show for the first time, that it is possible 
to display a heterotretrameric human enzyme in an active 
form on the surface of E. coli, when using the AIDA-I 
autotransporter for autodisplay.
Methods
Bacterial strains and culture conditions
Escherichia coli BL21(DE3) [23] was used for the expres-
sion of autotransporter fusion proteins. Bacteria were 
routinely grown at 37°C in lysogeny broth (LB) contain-
ing 50 mg/L carbenicillin or 30 mg/L kanamycin or both, 
depending on the plasmid-encoded antibiotic-resist-
ance factor(s) they carried. For expression and activ-
ity studies, LB medium was supplemented with 10  µM 
ethylenediaminetetraacetate (EDTA) and 10 mM 2-mer-
captoethanol. Routinely, an E. coli liquid culture was 
grown overnight, and an aliquot of this culture (200 µL) 
was used to inoculate fresh LB medium (40  mL). Cells 
were cultivated at 37°C with shaking (200 rpm) until an 
OD578 of 0.6 was reached. Protein formation was induced 
by adding isopropyl-β-d-thiogalactopyranoside (IPTG, 
1 mM final concentration) for 60 min at 30°C.
Design of autotransporter fusion genes and expression 
plasmids
In order to prepare a CK2α-coding passenger domain, 
human CK2α cDNA (CSNK2A1) was amplified by PCR 
using the two oligonucleotides Pr199 (5′-CCA GTC GAC 
TCG GGA CCC GTG CCA AGC AGG GCC AGA GTT 
TA-3′) and Pr200 (5′-AAG GTA CCC TGC TGA GCG 
CCA GCG GCA GCT GGA ACA-3′) as primers and. 
The PCR product of 1,187  bp was a sequence without 
start- and stop codon, flanked by restriction endonu-
clease recognition sites (a SalI site at the 5′ end and an 
Acc65I site at the 3′ end). After cleavage with SalI and 
Acc65I, the fragment was ligated in-frame into an auto-
display plasmid (pBL002) that already contained an auto-
display fusion gene encoding signal peptide, passenger, 
linker and β-barrel (Figure  1). The plasmid pBL002 is a 
derivative of pBL001, which has been described before 
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[17], but contained a 1.4 kBp NOX-encoding fragment 
in the XhoI/KpnI cloning site of pBL001. This passenger-
encoding domain was removed by a restriction digest 
with XhoI and Acc65I, yielding a plasmid backbone 
with compatible ends for the CK2α insert. The result-
ing 6,008  bp expression plasmid pCK2α-AT carried a 
2,613 bp autotransporter fusion gene for surface display 
of CK2α. For autodisplay of the β-subunit of CK2, a pre-
viously described autotransporter plasmid pJJ004 [14] 
was used as expression vector. The adrenodoxin-encod-
ing passenger domain of pJJ004 was replaced by CK2β. 
Therefore, human CK2β cDNA (CSNK2B) was amplified 
by PCR with primers Pr201 (5′-AAC TCG AGA GCA 
GCT CAG AGG AGG TGT C-3′) and Pr202 (5′-AAG 
GTA CCG CGA ATC GTC TTG ACT GGG CT-3′). 
PCR results in CK2β coding DNA fragment devoid of 
start- and stop-codon but with flanking recognition sites 
for endonucleases XhoI (5′ end) and KpnI (3′ end). After 
cleavage by XhoI and KpnI, the fragment was ligated in-
frame into XhoI/KpnI cleaved vector pJJ004, replacing 
the adrenodoxin-encoding domain and forming 7,724 bp 
plasmid pCK2β-AT containing the 2,082  bp autotrans-
porter fusion gene.
Outer membrane protein preparation  
and trypsin accessibility
After induction of protein formation, E. coli BL21(DE3) 
strains with either one or two plasmids, or without 
plasmid as controls, were harvested by centrifugation 
(3,850×g, 4°C, 10 min) and washed twice with 0.2 M Tris/
HCl (pH 8.0). Outer membrane proteins were enriched 
according to the rapid isolation method of Handke et al. 
[24] with modifications as described previously [25]. In 
detail, cells were lysed by adding lysozyme (0.04 mg/mL 
end concentration) in the presence of 10 mM saccharose 
and 1 μM EDTA in a final volume of 1.5 mL of Tris–HCl 
(0.2  M, pH 8), followed by an incubation for 10  min at 
room temperature. Subsequently aprotinin (10  µg/mL), 
phenylmethylsulfonyl fluoride (PMSF) (0.5 mM), as well 
as 5  mL of extraction buffer (50  mM Tris–HCl pH8.0, 
10  mM MgCl2, 2% Triton X 100) and DNAseI (10  µg/
mL) were added. The samples were incubated on ice for 
30  min and centrifuged for 5  min at 4°C (3,850×g) to 
remove intact bacteria and large cell debris. The super-
natants representing the clarified bacterial lysate were 
transferred to fresh tubes and centrifuged at higher speed 
(38,700×g) for 30 min at 4.0°C to obtain the membrane 
Figure 1 Structure of the a CK2α- and b CK2β-autotransporter fusion proteins. The restriction endonuclease recognition sites that were used for 
construction of the corresponding fusion genes are annotated and surrounding DNA- and amino acid sequences are given. The fusion protein 
domain sequence is as follows: the N-terminal signal peptide is needed for translocation through the bacterial inner membrane (sequence in italics) 
and is cut subsequently, the open reading frames of CK2α (a) or CK2β (b) are referred to as the passenger domain, which is supposed to be  
presented at the cell surface (given in bold letters). Linker and β-barrel domain facilitate translocation through and anchoring in the outer membrane.
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protein fraction. The resulting supernatants, contain-
ing soluble cytoplasmic and periplasmic proteins, were 
completely aspirated. The pellets were suspended in 
10 mL phosphate-buffered saline (PBS) plus 1% sarcosyl 
(N-lauryl sarcosinate, sodium salt) and centrifuged again 
(38,700×g, 60 min, 4°C). The supernatant after this step 
contained the sarcosyl-soluble cytoplasmic membrane 
proteins and was completely aspirated. The sediment 
representing the outer membrane protein fraction was 
washed twice with 10 mL of water and taken up in 30 µL 
purified water for SDS-PAGE. Because the outer mem-
brane proteins with surrounding parts of the outer mem-
brane lipids, as obtained thereby, are actually insoluble in 
water, this represents a suspension of outer membrane 
vesicles with an average diameter of 180 nm, containing 
the protein of interest [26]. For whole-cell protease treat-
ment, E. coli cells were harvested, washed and suspended 
in PBS (1 mL). Trypsin (Fluka, Sigma-Aldrich, Deishofen, 
Germany) was added to a final concentration of 2.5 g/L 
and cells were incubated for 1  h at 37°C. Digestion was 
stopped by adding 5  mL 10% fetal calf serum (FCS) in 
0.2 M Tris/HCl. After washing the cells twice with 5 mL 
0.2  M Tris/HCl the outer membrane fraction was iso-
lated. For SDS-PAGE, the outer membrane sample was 
dissolved in 20–40 µL PBS, depending on the yield. For 
co-immunoprecipitation it was dissolved in 20–40  µL 
kinase buffer (50  mM Tris/HCl, 100  mM NaCl, 10  mM 
MgCl2, 1 mM DTT, pH 7.5). Samples were stored at 4°C 
no longer than 2 days.
SDS‑PAGE and Western blot
Protein samples were diluted with SDS sample buffer 
(100 µM Tris/HCl, pH 6.8 with 4% SDS, 0.2% bromphe-
nol blue and 20% glycerol). Prior to separation, samples 
were boiled for 20 min and loaded onto a SDS-Gel con-
taining 7.5 or 10% acrylamide. PAGE Ruler unstained or 
prestained protein marker (Fermentas, St. Leon-Roth, 
Germany) was used as a molecular weight standard. After 
separation, the gel was stained with Coomassie brilliant 
blue G250 (Serva, Heidelberg, Germany). For Western 
blot, samples were separated via SDS-PAGE as described 
above using PAGE Ruler prestained protein marker (Fer-
mentas, St. Leon-Roth, Germany) and were subsequently 
transferred onto a PVDF membrane by tank-blotting. 
After blocking for 1  h in TBST [TBS (pH 7.4) contain-
ing 0.1% Tween 20] supplemented with 5% dried milk, 
the blot was incubated for 4 h with an anti CK2β-serum 
(polyclonal rabbit serum, raised against amino acids 206–
215 of CK2β-subunit, Serum# 32, [27]), diluted 1:5,000 in 
TBST, followed by three washing steps with TBST. The 
membrane was then incubated for 1 h with the secondary 
antibody [HRP-coupled anti rabbit IgG (#AO545, Sigma-
Aldrich, Deishofen, Germany), dilution of 1:10,000 in 
TBST] followed by two washing steps with TBST and 
one with TBS. The immune complex was visualized via 
chemiluminescence (ImmunoCruz kit, Santa Cruz bio-
technology, Heidelberg, Germany).
Co‑immunoprecipitation
250  µg protein A/G magnetic beads (Pierce-Thermo 
Scientific, Rockford, IL, USA) were mixed with 10  µg 
monoclonal mouse antibody #1A5, (mouse monoclonal 
antibody against CK2α [28]) in 500  µL binding buffer 
(150 mM NaCl, 25 mM Tris/HCl, 1 mM EDTA, 1% NP40, 
5% glycerol, pH 7.4). After 15 h at 8°C under gently shak-
ing, the supernatant was discarded. The antibody-loaded 
beads were washed and suspended in 500  µL binding 
buffer and mixed with 25 µL E. coli outer membrane frac-
tion. The beads were precipitated after 4  h at 22°C and 
the supernatant was collected. The beads were washed 
twice with binding buffer, and once with deionized water, 
before the immune complex was eluted by heating (95°C 
for 20  min) in SDS sample buffer containing 200  mM 
DTT. Eluted proteins (precipitate) and supernatant were 
analyzed by SDS-PAGE and Western blot analysis using 
the polyclonal rabbit anti-CK2β-serum [27].
Radiometric whole‑cell CK2 activity
CK2-activity of whole bacterial cells was determined in 
a radiometric assay usually applied for in vitro testing of 
the purified enzyme [29]. The transfer of a [32P]-phos-
phate from ɣ[32P]-ATP onto the CK2-specific substrate 
peptide RRRDDDSDDD [30] is quantified. Here, E. coli 
cells presenting CK2 subunits were tested, instead of 
using the purified enzyme. E. coli strains were grown 
and protein production was induced as described above. 
Cells were harvested by centrifugation (3,850×g, 4°C, 
10 min) and washed three times with kinase buffer. Cells 
were suspended in 20 µL kinase buffer to reach an opti-
cal density at 578  nm (OD578) of 2.5 (2.15  ×  108 cells/
mL). In case of inhibitor testing, cells were suspended in 
19.5 µL kinase buffer to reach an OD578 of 2.56. Inhibi-
tor was dissolved in pure DMSO and 0.5 µL of inhibitor 
solution was mixed with the cells and incubated at 37°C 
for 10  min. The reaction was started by adding 30  µL 
hot assay buffer (150 mM NaCl, 25 mM Tris/HCl, 5 mM 
MgCl2, 0.19  mM substrate peptide RRRDDDSDDD, 
0.6 µCi ɣ[32P]-ATP, 100 µM ATP, pH 8.5), diluting the cell 
suspension to reach OD578 = 1 in a final volume of 50 µL 
(equals 8.6 × 107 cells/mL). CK2 activity was calculated 
via measuring the amount of incorporated radioactive 
phosphate residue in counts per minute (cpm) after bind-
ing the peptide to P81 ion exchange paper and scintilla-
tion counting. Inhibition by TBB was determined after 
pre-incubating CK2 with the inhibitor for 10 min before 
adding the hot assay buffer.
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Whole‑cell CK2 activity assay and inhibition testing 
by capillary electrophoresis
The enzymatic activity of surface-displayed protein 
kinase CK2 and the IC50-values were determined using 
a recently published CE-assay [29] with slight modifica-
tions. In summary, 78  µL of the prepared bacteria sus-
pension in kinase buffer were supplemented with 2  µL 
of the test-compound dissolved in DMSO and incu-
bated for 15 min at 37°C and 400 rpm. CK2-reaction was 
started by the addition of 120 µL of assay buffer (25 mM 
Tris/HCl, pH  8.5, 150  mM NaCL, 5  mM MgCl2, 1  mM 
DTT, 167  µM substrate peptide RRRDDDSDDD and 
100  µM ATP) and was carried out for 60  min at 37°C 
and 400 rpm. Final concentration for the substrate pep-
tide RRRDDDSDDD was 100  µM and for ATP 60  µM 
with a cell concentration of OD578 = 2 (equals 1.72 × 108 
cells/mL) in a total volume of 200 µL. After the removal 
of CK2-presenting bacteria by centrifugation at 3,850×g 
(10 min, 4°C), the supernatant was transferred to a 96 well 
microplate. CK2-reaction was terminated by lowering to 
temperature to 4°C and complexing divalent cations with 
12.5 mM EDTA before it was analyzed by capillary elec-
trophoresis. For the determination of IC50 values, a sam-
ple incubated with pure DMSO served as a control for 0% 
inhibition, whereas a sample without the addition of ATP 
served as a control for 100% inhibition. The IC50 value of 
TBB was determined using nine different concentrations 
in appropriate intervals ranging from 100 pM to 10 µM. 
For silmitasertib, dose–response data using nine concen-
trations in appropriate intervals ranging from 10 pM to 
1 µM were analyzed for IC50 determination.
Influence of NaCl on the enzymatic activity of surface 
displayed CK2α and CK2 holoenzyme
For this purpose, enzymatic activities of whole cell either 
displaying CK2α or CK2α and CK2β were determined as 
described above for IC50 values with slight modifications. 
Briefly, 80 µL of the bacteria suspension in kinase buffer 
(50 mM Tris/HCl, pH 7.5, 20 mM MgCl2 and 1 mM DTT) 
with eight different concentrations of NaCl concentra-
tions ranging from 0 to 300 mM were incubated at 30°C 
and 400 rpm for 15 min. CK2-reactions were initiated by 
the addition of 120 µL of assay buffer (25 mM Tris/HCl, 
pH  8.5, 20  mM MgCl2, 1  mM DTT, 167  µM substrate 
peptide RRRDDDSDDD and 1  mM ATP) having the 
identical concentration of NaCl as the sample with the 
kinase buffer they were added to. Final concentrations in 
a total volume of 200 µL were 100 µM for the substrate 
peptide and 600 µM for ATP with a final cell density of 
OD578 = 2, which corresponded to ~1.7 × 108 cells/mL. 
For each sample enzymatic reaction was run for 60 min 
at 30°C and 400 rpm. CK2 displaying bacterial cells were 
removed by centrifugation at 3,850×g for 10 min at 4°C 
and the supernatant was transferred to a well of a micro-
plate (96 well format). There 12.5 mM EDTA was added 
at 4°C to remove any free divalent cations and definitely 
stop the enzymatic reaction. Subsequently phosphoryla-
tion of the substrate peptide was analyzed by capillary 
electrophoresis as described above.
Results
Autodisplay of CK2 subunits α and β
For surface display of CK2α and CK2β, two artificial 
fusion genes were constructed, each of which con-
tained sequences coding for essential domains for auto-
display and an open reading frame for CK2α or CK2β, 
respectively. The resulting fusion genes encoded a 
fusion protein with the following domain architecture: 
An N-terminal signal peptide, the passenger domain 
(either CK2α or CK2β subunit), a linker sequence and 
the β-barrel domain that anchors the surface-exposed 
passenger in the outer membrane of Gram-negative E. 
coli. For autodisplay of both CK2 subunits two individ-
ual fusion proteins were produced and anchored in the 
outer membrane: CK2α-AT containing CK2α subunit as 
the passenger domain (Figure 1a) and CK2β-AT, contain-
ing CK2β subunit as the passenger domain (Figure  1b). 
Protein production was facilitated in both cases by using 
plasmids with the strong T7 promoter for IPTG-induc-
ible expression in E. coli via a T7 RNA polymerase gene 
under UVlac5 control. E. coli strain BL21(DE3) was used 
as a host for autodisplay due to its deficiency of outer 
membrane protease OmpT.
The absence of OmpT avoids the cleavage of the auto-
displayed protein on the cell surface. E. coli BL21(DE3) 
was transformed with either expression plasmid pCK2α 
(encoding CK2α-AT) or pCK2β (encoding CK2β-AT) or 
with both plasmids. For maintaining both plasmids in 
a single cell, bacteria were grown in such case with the 
two antibiotics carbenicillin and kanamycin. Following 
growth and induction of protein formation, the individ-
ual outer membrane-containing fraction of each strain 
was analyzed by SDS-PAGE.
In all samples, a strong expression of the autotrans-
porter fusion proteins could be detected when comparing 
the samples of the plasmid containing strains with that 
of the host strain outer membrane fraction (Figure 2). In 
samples of E. coli BL21(DE3) pCK2α, the expected molec-
ular weight of 95  kDa for CK2α-AT was in agreement 
with the appearance of a protein at an apparent molecu-
lar weight in this range (Figure 2, line 5). The same is true 
for expression of CK2β-AT in E. coli BL21(DE3) pCK2β, 
where the apparent molecular weight of the extra band 
corresponded to CK2β-AT’s predicted size of 74  kDa 
(Figure  2, line 7). It appeared from the density of the 
CK2 fusion protein bands, that expression of CK2β-AT 
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was much more efficient than expression of CK2α-AT. 
This could have been due to several reasons. First of all, 
because both human sequences were not codon opti-
mized for expression in E. coli, the presence of rare codons 
in CKα could interfere with its expression, whereas such 
effect could be less severe in CK2β. Second, it could have 
been the result of a gene dosage effect, namely that the 
copy number of the plasmid encoding Ck2α, with the 
pET vector backbone (ColE1 origin of replication) was 
less than the copy number of the plasmid encoding CK2β, 
based on the pCOLADuet backbone (ColA origin). Both 
vectors, however, were described to be medium copy 
number plasmids with about 15–40 copies per cell [31]. 
At this point, it seems unlikely, that Coomassie staining 
of CK2α was less efficient than staining of CK2β, because 
such a difference in Coommassie staining of both subu-
nits was not observed when the recombinant human CK2 
holoenzyme was analyzed by SDS-PAGE [32].
Following the successful individual expression of both 
CK2 subunits, E. coli BL21(DE3) was transformed with 
both plasmids, pCK2α and pCK2β to enable co-expres-
sion and autodisplay of CK2α-AT and CK2β-AT in a sin-
gle strain. Analysis of outer membrane isolates indicated 
that while the expression level of CK2β-AT was identical 
to that in the strain displaying CK2β-AT alone, a further 
decrease in expression of CK2α-AT was observed in com-
parison to the expression of CK2α-AT alone (Figure  2, 
line 3). This could be a first indication, that indeed codon 
usage could account for this effect.
A presence of the fusion protein in the outer mem-
brane fraction of E. coli alone does not prove surface 
exposure of its passenger domain. The addition of the 
protease trypsin to an E. coli suspension is a commonly 
used tool to examine passenger accessibility from the 
outside [33, 34]. Trypsin is considered too large for cross-
ing the outer membrane. Thus, if the passenger domain 
is not exposed to the surface, trypsin is not able to access 
the fusion protein and it stays intact. In case the passen-
ger domain is directed towards the surface, the fusion 
protein can be digested and its molecular weight will be 
reduced. On the other hand, if the integrity of the outer 
membrane was infringed, the protease would enter the 
periplasm and the fusion protein would be degraded 
independent from its orientation. In the latter case how-
ever, OmpA would be degraded as well due to its C ter-
minal extension which is covalently linked to the murein 
layer of the cell wall. For this reason, appearance of 
full-length OmpA in an outer membrane fraction after 
trypsin treatment of whole cells is an internal control for 
the integrity of the outer membrane and hence a prereq-
uisite for the validity of the experiment. In conclusion, if 
full-length OmpA is present and the full-length fusion 
protein is degraded, there is strong evidence for surface 
exposure of the passenger domain. Trypsin treatment 
of whole cells displaying either CK2α, or CK2β or both 
subunits resulted in a substantial decrease of full-length 
autodisplay fusion proteins in all cases (Figure 2, lines 4, 
6 and 8). Due to the high expression level of CK2β-AT, it 
Figure 2 Outer membrane preparation of CK2-presenting E. coli. Outer membrane samples were separated by SDS-PAGE (7.5% acrylamide) and 
stained with Coomassie brilliant blue. For autodisplay of the individual CK2 subunits, E. coli BL21(DE3) pCK2α (lanes 5 and 6) or E. coli BL21(DE3) 
pCK2β (lanes 7 and 8) was used, for autodisplay of both subunits in one strain E. coli BL21(DE3) pCK2α pCK2β (lanes 3 and 4) was used. A fraction of 
each whole cell sample was treated with trypsin before preparation of outer membranes to degrade surface presented proteins facing toward the 
extracellular medium (lanes 2, 4, 6 and 8). The host strain without any autodisplay construct served as a control (lane 1 and 2).
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was not degraded completely after trypsin treatment of 
whole cells and a faint CK2β-AT band is still visible after 
SDS-PAGE (Figure  2, lane 8). In contrast, the modestly 
expressed CK2α-AT could be hydrolyzed almost com-
pletely by trypsin (Figure 2, lane 6). The outer membrane 
integrity could be ensured in all samples: the marker pro-
tein OmpA appeared in its full-length form and was not 
affected by trypsin treatment. These results clearly indi-
cate the surface-exposure of both CK2 subunits, when 
separately expressed or when simultaneously expressed 
in E. coli BL21(DE3).
Interaction of CK2α and CK2β on the cell surface
The β-barrel domain anchors the autotransporter fusion 
protein in the outer membrane and its motility within 
the plane of membrane has been shown to enable pas-
senger-driven clustering of multimeric proteins [7]. Due 
to the strong affinity between both CK2 subunits in vitro 
(KD = 4 nM) [2], CK2 subunits assemble spontaneously 
from individually purified CK2α and CK2β. Based on 
this scenario, surface-presented CK2α and CK2β could 
interact on the cell surface to form a functional holoen-
zyme. The anticipated interaction of both displayed CK2 
subunits was investigated by a co-immunoprecipitation 
approach. Therefore, outer membrane preparation of 
CK2 expressing E. coli BL21(DE3) strains were precipi-
tated with a monoclonal anti-CK2α antibody (1A5) [28] 
and analyzed for co-precipitated CK2β-AT. An interac-
tion between CK2α- and CK2β-subunit was found by 
the occurrence of CK2β-AT in such precipitates in SDS-
PAGE and Western blot immunostained with an anti-
CK2β antiserum [27] (Figure 3).
CK2α-AT precipitation was shown in all membrane 
samples of CK2α-AT expressing strains by the appear-
ance of a 95  kDa protein band (Figure  3a, lanes 3, 5). 
Precipitation after co-expression of CK2α and CK2β 
yielded a clear band on a SDS-PAGE gel at the expected 
molecular weight of the CK2β-AT protein (74 kDa) (Fig-
ure 3a, lane 3). Moreover, in the corresponding Western 
blot the 74 kDa band was labeled by the anti CK2β anti-
serum, confirming that indeed CK2β was co-precipitated 
with CK2α (Figure 3b, lane 3). As can be seen in lanes 2 
of Figure 3a and b, CK2β was not completely co-precip-
itated with the anti CK2α beads, and hence still present 
in the supernatant. This can be due to the much stronger 
expression of CK2β in comparison to CK2α on the cell 
surface (Figure 2, lane 3), which is supposed to result in 
an excess of CK2β and in consequence, in free CK2β mol-
ecules on the cell surface in addition to those interacting 
with CK2α.
The corresponding controls indicated that in the outer 
membrane fractions containing only CK2β-AT or no 
CK2 subunit at all, no 74 kDa protein was precipitated by 
the anti CK2α antibody (Figure 3a, lanes 5, 7). Applica-
tion of the identical precipitation protocol to outer mem-
brane fractions of CK2β-displaying strain resulted in a 
tiny amount of CK2β-AT (Figure  3a, lane 7), probably 
caused by an unspecific interaction of CK2β-AT with 
the antibody-coated beads. Due to the very small quan-
tity of this precipitate, it does not contribute significantly 
to the huge amount of precipitate found in samples with 
CK2α-AT and CK2β-AT, and can be disregarded. In the 
Western blot of the controls, these findings were con-
firmed: just a faint band was detected when trying to 
precipitate the CK2β-containing sample (Figure 3b, lane 
7). In samples using antibody 1A5 alone (Figure  3a, b, 
lanes 1), and without autodisplay of CK2β (Figure 3a, b, 
lane 4) no protein band of 74  kDa was detectable after 
Figure 3 Detection of CK2 α and β subunit interaction on the 
bacterial surface. Outer membrane preparations of E. coli strains were 
precipitated with anti-CK2α antibody-loaded beads. The superna-
tant as well as the precipitate of each sample were separated on 
a SDS-Gel (10% acrylamide), stained with Coomassie brilliant blue 
(a) or analyzed by Western blotting using an anti-CK2-β serum for 
co-precipitation of CK2β-AT (b). OmpF and OmpA in the supernatant 
fraction served as an internal control for the concentration of outer 
membrane proteins.
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co-precipitation, excluding the possibility of a mistaken 
identity of the CK2β-AT band. As a result, the co-pre-
cipitation of CK2β-AT and CK2α-AT showed an affinity-
based complex formation of α- and β-subunit on the cell 
surface, which was a first indication for a possible correct 
folding and assembly of the CK2 holoenzyme.
Kinase activity of E. coli cells displaying CK2α 
and CK2α + CK2β
The phosphotransferase activity of E. coli BL21(DE3) 
strains, displaying either CK2α and CK2β alone or in 
combination, was examined by a commonly used radio-
metric filter binding assay with the standard CK2-specific 
substrate peptide RRRDDDSDDD (Figure 4).
No kinase activity could be detected for the host strain 
E. coli BL21(DE3) (1,264  cpm) or for the strain that 
displayed CK2’s catalytically inactive β domain alone 
(1,264 cpm). In contrast, autodisplay of CK2α results in 
a phosphorylation of the peptide RRRDDDSDDD with 
a value of 7,638 cpm. The co-expression strain, present-
ing both CK2 subunits, yielded an even higher activity 
(9,802  cpm), although the expression level of the cata-
lytic CK2α-AT was reduced by a factor of 5 compared to 
a separate expression (Figure  2, lanes 3, 5). If the activ-
ity is normalized to the expression level, autodisplay of 
both subunits yielded a >5-fold increase over the activ-
ity of the CK2α-presenting strain alone. This takes into 
consideration that reduction of the expression level of the 
catalytic subunit CKα, will lead to reduction of available 
active sites to the same extent. Obviously, autodisplay of 
CK2β along with CK2α stimulates CK2 activity, which 
was a further hint on a possible functional subunit inter-
action at the E. coli cell surface. In order to exclude any 
false-positive activity data in the whole-cell assay, the E. 
coli strain displaying both subunits was treated with the 
selective CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole 
(TBB). In a concentration of 10  µM, TBB almost com-
pletely blocked CK2 activity (1,809  cpm), thus confirm-
ing that in fact the activity of surface-displayed CK2 was 
responsible for peptide phosphorylation. However, the 
high standard deviation in the radiometric whole-cell 
assay makes this assay format inappropriate for rou-
tine inhibitor screenings. To eliminate the unfavorable 
deviations, the radiometric filtration binding assay was 
replaced by a recently developed CK2 assay based on 
capillary electrophoresis (CE) [29]. Originally, this assay 
was described as an inhibition test for purified CK2, but 
the use of E. coli cells displaying CK2α and CK2β also 
resulted in a conversion of the substrate peptide RRRD-
DDSDDD in the CE-assay. A substrate phosphorylation 
of about 10–15% was achieved after 60  min by a cell 
suspension with an OD578 =  2 (1.72 ×  108 cells/mL) in 
the assay volume of 200 µL. With these settings, an ini-
tial CK2 reaction velocity (vi) could be recorded in all 
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Figure 4 Radiometric CK2 assay using CK2-presenting E. coli. The amount of transferred 32P from γ-[32P]-ATP onto the synthetic substrate peptide 
RRRDDDSDDD was quantified in counts per minute (cpm). Reactions were catalyzed by surface display of CK2β [E. coli BL21(DE3) pCK2β], CK2α  
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following experiments using surface-displayed CK2. In 
contrast to the radiometric assay, the quantification of 
CK2 activity resulted in a considerably lower standard 
deviation.
CK2 holoenzyme formation on the cell surface
Interaction of CK2α-AT and CK2β-AT on the cell surface 
alone is not sufficient to prove heterotetrameric CK2 hol-
oenzyme formation. Although CK2α/CK2β dimers have 
not been observed yet, and heterotetramer formation is 
generally considered to proceed by formation of a CK2β 
dimer, which subsequently collects two α-subunits to 
form the heterotetramer, further experimental evidence 
was required in order to validate that this can happen 
on the cell surface as well. At this point it appears worth 
mentioning, that the linker domain between the CK2α 
and β subunit passengers and the membrane anchored 
β-barrel domain (Figure  1a, b), comprised 160 amino 
acid, which were shown before to provide sufficient flexi-
bility to allow passenger domains to interact e.g. in oppo-
site directions without hampering enzymatic activity [9, 
11]. From the number of amino acids and the flexibility 
of the linker domain, it was suggested, that it would not 
interfere with the critical N terminus of the α-subunit 
and in addition, the complex growth medium used to 
cultivate the E. coli cells, which contained 5  g/L yeast 
extract, provided sufficient zinc ions, which are required 
for the initial dimerization of the β-subunits.
For further experimental evidence, the NaCl depend-
ency of surface displayed CK2α and surface co-displayed 
CK2α + CK2β were investigated. It has been known for 
a long time, that the enzymatic activity of human CK2 is 
dependent on the NaCl concentration in the assay. [35–
38]. Interestingly, the influence of NaCl is different in case 
the enzymatic activity of the holoenzyme is determined, 
in comparison to the activity of the catalytic α-subunit 
alone. Whereas the α-subunit is more and more inhibited 
by increasing concentrations of NaCl, finally leading to 
an almost completely inactive enzyme, the holoenzyme 
is activated by increasing concentrations of NaCl [39]. 
Therefore we measured the enzymatic activity of cells 
displaying either the α-subunit alone, or the α-subunit 
together with the β-subunit in the CE-assay with the sub-
strate peptide RRRDDDSDDD in the presence of differ-
ent concentrations of NaCl, ranging from 0 to 300 mM.
As shown in Figure 5, a NaCl concentration of 25 mM 
strongly decreased the enzymatic activity of cells display-
ing only CK2α. Increasing concentrations of NaCl lead 
to further inhibition of Ck2α ending up with an almost 
negligible enzymatic activity at a NaCl concentration of 
300 mM. In contrast, increasing concentrations of NaCl 
activated the enzymatic activity of cells displaying Ck2α 
together with CK2β with the highest activity obtained at 
a concentration of 150 mM. Further increase of NaCl to 
concentrations of 200 or 300 mM still activated the enzy-
matic activity of these cells, but not to the same extent 
as observed at 150 mM. The curves of activity that were 
obtained with the surface displayed CK2α and with sur-
face displayed CK2α  +  CK2β were almost completely 
congruent with those obtained earlier for the free CK2α 
subunit and CK2 holoenzyme [39]. Consequently, it was 
concluded that co-expression of CK2α and CK2β on the 
surface of E. coli must have led to the formation of an 
active CK2 holoenzyme.
Inhibitor testing
The easy access to the drug target CK2 by autodisplay 
enables the implementation of an assay without the 
need to purify the CK2 holoenzyme. Based on this idea, 
a dose-dependent inhibition of autodisplayed CK2, by 
TBB, a known inhibitor with a benzotriazole scaffold 
(4,5,6,7-tetrabromobenzotriazole) was determined in 
the CE assay with the substrate peptide RRRDDDSDDD. 
The concentrations of the inhibitor applied range from 
100  pM to 10  µM and resulting enzymatic activity lead 
to the determination of an IC50 value of 0.05 µM of TBB 
(Figure 6a).
This IC50 value is in agreement with the value of 
0.06 µM, obtained in a CK2-assay with purified free CK2 
holoenzyme [32]. In addition, the IC50 value of silmita-
sertib (5-(3-chloro-phenylamino)benzo[c][2, 6]naphthyr-
idine-8-carboxylic acid, CX4945), one of the most potent 
CK2 inhibitors known, and at present in clinical trials, 
Figure 5 Influence of NaCl on surface displayed human CK2α (filled 
circle) and surface displayed human CK2α + CK2β (filled square). 
Increasing concentrations of NaCl ranging from 0 to 300 mM were 
applied, and the kinase activity of cells either displaying CK2α or 
CK2α + CK2β were determined by the CE assay. The substrate 
peptide (RRRDDDSDDD) concentration was 100 µM and the ATP-
concentration was 600 µM. Activity was measured for 60 min at 30°C 
with cells of an OD578 = 2, which corresponds to 1.72 × 108 cells/mL. 
Samples without NaCl were set to 100% activity.
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was also assessed with the surface-displayed CK2 holo-
enzyme. The resulting IC50 of 3.3 nM (Figure 5b) is in line 
with the IC50 value of 3.7  nM that was published using 
purified CK2 holoenzyme in the CE-assay [32]. Moreo-
ver, it is in good agreement with the IC50 value of 1 nM 
that Pierre et  al. [21] originally reported using a radio-
metric assay with a slightly different ATP concentration. 
The reliable quantification of in vitro inhibition and the 
unity of both IC50 values with published data obtained 
with the purified enzyme indicate suitability of surface-
displayed CK2 for screening and characterization of CK2 
inhibitors.
Discussion
The functional autodisplay of pharmaceutically interest-
ing target proteins on the surface of E. coli provides an 
alternative to protein purification and appears to be a 
powerful tool for enzyme assays. It proved especially 
advantageous, if the target protein is unstable in its puri-
fied form or builds inclusion bodies upon intracellular 
expression. The autotransporter secretion machinery, 
which is used by autodisplay, keeps the fusion protein 
in an unfolded state until it is being translocated. This 
feature obviously helps avoiding (intracellular) target 
protein inclusion bodies. Heterologous expression of 
human hyaluronidase 1 (Hyal-1) in E. coli, for example, 
was shown to form inclusion bodies resulting in an inac-
tive enzyme that can exclusively be found in the insolu-
ble E. coli cell fraction. Even optimized refolding yielded 
extremely low hyaluronidase activity [40]. The produc-
tion of hyaluronidases in eukaryotic expression systems 
provided low yields, representing a bottleneck in early 
drug discovery. Autodisplay of human hyaluronidase 
hPH-20 circumvents the forming of inclusion bodies and 
results in surface-displayed, active enzyme that can be 
used for inhibitor screenings [41]. The concept of a quick 
and cost-effective surface display of target enzymes was 
applied to protein kinase CK2.
In this report we describe the successful surface-dis-
play of active human CK2 on the cell surface of E. coli by 
autodisplay. The fusion proteins CK2α-AT and CK2β-AT 
were expressed together or individually in E. coli, translo-
cated to the cell surface and anchored in the outer mem-
brane. In whole cell samples, trypsin was able to access 
and degrade the fusion proteins, confirming their surface 
exposure. Not only kinase activity of whole E. coli cells 
after autodisplay of the catalytically active subunits CK2α 
was detectable, moreover, combined autodisplay of CK2α 
and CK2β lead to the formation of an active holoenzyme 
at the cell surface as it was indicated by its NaCl activa-
tion. The important role of CK2β for stability and protec-
tion of CK2α against denaturing agents and proteolytic 
degradation was reported for the reconstituted purified 
recombinant holoenzyme by Meggio et  al. [42]. Simi-
larly, the activity data presented here show that CK2β-AT 
helps stabilizing CK2α-AT in an active conformation. A 
formation of CK2α/β complexes found in co-precipita-
tion experiments mechanistically supported the possible 
assembly of a holoenzyme-like CK2 complex. Although 
passenger-driven assembly of a quaternary complex at 
the cell surface has been demonstrated for homomeric 
enzymes, autodisplay of a fully functional heteromeric 
enzyme has been reported in this study for the first time.
A major disadvantage in the autodisplay of CK2, 
which requires further improvement is the different 
expression levels obtained for CK2α and CK2β. This dif-
ference in expression even increased when both subu-
nit were co-expressed on the surface of a single cell. 
Because the promoters used in both expression plas-
mids were identical, and the copy number derived from 
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Figure 6 Dose-dependent inhibition of surface-displayed CK2  
measured by the CE-assay. E. coli BL21(DE3) pCK2α pCK2β was  
incubated with different concentrations of a TBB (100 pM–10 µM) 
or b silmitasertib (10 pM–1 µM) for 10 min before the reaction was 
started. CK2 activity was determined by capillary electrophoretic 
quantification of product rate. The fractional inhibition values were 
calculated in respect to an uninhibited sample and are given as mean 
values (±standard deviation, n = 3). The IC50 values were obtained 
by fitting the dose-dependent inhibition data to a sigmoidal four-
parameter logistic equation.
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the origins of replication in both plasmids, either ColE1 
or ColA were reported to be (mostly) identical (15–40 
copies per cell), a different effect needs to be the reason. 
We analyzed the codon usage in the human sequences 
of CK2α and CK2β as applied here for expression in 
E. coli as fusion proteins with the autotransporter 
domains. The CK2β sequence contained 12 codons out 
of 215, which are rarely used in E. coli, with only three 
codons for tRNAs available equal or less than 3%. In 
contrast, the CK2α sequence contained 30 codons out 
of 391, which are rarely used in E. coli, with nine codons 
for tRNAs available equal or less than 3%. Moreover, 
six of the human codons rarely used in E. coli are pre-
sent in CKα within a single stripe encoding amino acids 
residues 168–173. This could be a hint that indeed the 
different codon usage in both human subunits accounts 
for the observed differences in expression of surface dis-
played CK2α and CK2β. The next step will be to opti-
mize the codon usage for both subunits with respect 
to the host organism E. coli, and find out whether this 
will lead to more equal expression. In addition it should 
lead to an increase in the activity of whole cells display-
ing CK2α, but of cells displaying CK2α + CK2β, as well. 
As indicated in the co-precipitation experiments (Fig-
ure 3a, b, lanes 2), at current, there appears to be a sur-
plus of CK2β subunits, which are unable to gather CK2α 
binding partners.
We used the different NaCl dependency of CK2α and 
CK2 holoenzyme [39] in order to elucidate holoenzyme 
formation by surface displayed α- and β-subunits. The 
phosphotransferase activity of cells displaying CK2α was 
inhibited by increasing concentrations of NaCl, whereas 
the activity of cells displaying CKα  +  CK2β were acti-
vated with increasing concentrations of NaCl, as it was 
reported before for free CK2α and CK2 holoenzyme 
[39] and thus indicating the formation of functional CK2 
holoenzyme on the cell surface. Moreover the curves 
obtained in both cases, i.e. catalytic activity versus NaCl 
concentration were almost identical with those obtained 
with the free α-subunit and the free holoenzyme, Calmo-
dulin is a substrate protein that has been reported to be 
preferably phosphorylated by the α-subunit and the reg-
ulatory β-subunit in the holoenzyme almost completely 
inhibits its phosphorylation. This inhibitory effect may 
be overcome by polybasic peptides [42]. But because on 
one hand, this is a rather gradual effect and calmodu-
lin is quite expensive, and on the other hand, the results 
obtained with the NaCl dependency of the catalytic 
activities were such unambiguous, we abstained from this 
approach. Whereas the homodimerization or homomul-
timerization of enzyme subunits expressed at the cell sur-
face of E. coli has been reported earlier [8, 9, 16, 43, 44], 
this is the first report on the functional surface display 
of a heterotetrameric enzyme by displaying the subunits 
individually.
CK2 activity can easily be produced with the presented 
autodisplay system just-in-time for inhibition screenings 
or for kinetic studies of potential CK2 inhibitors. The 
often complex and time-consuming purification pro-
cess can be avoided and “fresh” enzyme activity is avail-
able within 1  day, while storage artifacts like partially 
inactive or degraded enzyme species can be massively 
reduced. During intracellular recombinant expression 
and purification of CK2α for example, a fraction of the 
protein loses a C terminal domain of 54 amino acids due 
to spontaneous degradation [45]. Although the activity 
and the interaction of this truncated CK2α with CK2β 
remain unaltered, the degradation might affect some 
features other than kinase activity and hence should be 
minimized as much as possible [46, 47]. When CK2α is 
produced as an autodisplay-passenger, its C terminus is 
obviously protected from the described degradation and 
the full-length autodisplay fusion protein CK2α-AT was 
detected in SDS-PAGE. This stabilization of sensitive 
proteins, which require a solid support or a membrane 
environment for their functional integrity, is a known 
general benefit of autodisplay. In similar cases this was 
shown previously, e.g. for cytochrome P450 enzymes, 
which need a lipophilic surrounding for their enzymatic 
activity. Autodisplay of CYP106A2 and CYP3A4 yielded 
whole cell biocatalysts converting P450-specific sub-
strates [10, 25].
There are a few important factors to consider when 
using a whole-cell biocatalyst instead of a purified 
enzyme. First, the applied activity assay needs to toler-
ate living E. coli organisms and the assay conditions (pH, 
solvents, etc.) must be chosen carefully so that the cel-
lular integrity of E. coli is not disrupted. Bacterial cells 
remained intact during the assays as described, but in 
the radiometric kinase assay, the whole-cell approach 
may have contributed to the high standard deviation. The 
presence of E. coli in the CK2 reaction indeed showed an 
additional peak during CE analysis. However, the addi-
tional peak did not interfere with product quantification. 
Second, the assay substrate(s) and products may not be 
taken up actively and may not be metabolized by E. coli. 
The CK2 substrate peptide RRRDDDSDDD (including its 
phosphorylated form) is considered too large to cross the 
outer membrane of E. coli and in fact, we could not detect 
a decrease of substrate peptide concentration upon incu-
bation with E. coli for >1 h. The impermeability of the cell 
envelope for the substrate peptide is another proof for 
the surface exposure of CK2, since its detected phospho-
rylation must be catalyzed by the surface-displayed CK2. 
An uptake of the CK2 co-substrate ATP cannot be fully 
excluded, since the outer membrane porin OmpF allows 
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the passive diffusion of small (<600–700  Da) hydro-
philic substances. In our experiments, however, surface-
presented CK2 was still active >2  h after reaction start. 
If there is a decrease of ATP concentration caused by 
an uptake by the bacteria, it is in a very small order of 
magnitude. A recent report supports the notion that an 
uptake of ATP by E. coli even with minimum medium 
is very slow [48]. Third, due to the complex nature of a 
whole-cell biocatalyst, the concentration of active protein 
cannot be determined exactly. It must be deduced from 
SDS-PAGE of whole cell lysates or outer membrane frac-
tions and then be compared to a stably expressed internal 
standard, like OmpA. At this point it needs to be taken 
into consideration, that the anchoring of the enzyme in 
the outer membrane by the β-barrel, which in conse-
quence means, that its C terminus is covalently linked 
to the N terminus of the linker, which could also have an 
effect on enzymatic activity. This has been shown before, 
e.g. for surface displayed sorbit dehydrogenase, with 
an altered substrate specicity of the surface displayed 
enzyme in comparison to the free molecule [43] or for 
prenyltransferase, for which surface display surprisingly 
increased the enzymatic activity in comparison to the 
free enzyme [8]. For comparing the activity of surface dis-
played CK2α with the activity of the free enzyme, we first 
determined the number of CK2α molecules per single 
cell of E. coli. For this purpose, the optical densities of the 
bands for CK2α, as well as for OmpA, were determined 
in lane 5 of the Coomassie stained SDS gel shown in Fig-
ure  2. The optical density of the CK2α-autotransporter 
fusion protein was 2.83 times higher than that of OmpA. 
Because OmpA is known to have a constant number of 
105 molecules per single cell [49], we could calculate the 
molecules of the CK2α-autotransporter fusion protein 
per single to be 1.1 ×  105, by taking into consideration 
the different molecular weights of both proteins (95 and 
35  kDa, respectively). Because the activity of a 200  µL 
cell suspension of an OD578 = 2 (equals 1.72 × 108 cells/
mL) without NaCl was 1.37 ×  10−5  µmol/min, as indi-
cated in Figure 5, the enzymatic activity of a single CK2α 
molecule displayed at the cell surface was estimated to 
be 3.66 × 10−18 µmol/min. The enzymatic activity of free 
purified CK2α was determined by CE under identical 
conditions with 0.2 µg of protein in 200 µL. This resulted 
in an activity of 3.66 × 10−5 µmol/min. Taking the molec-
ular weight of free CK2α subunit into account, which is 
45 kDa, an enzymatic activity of 1.16 × 10−17 µmol/min 
per single molecule could be estimated. In summary the 
activity of surface displayed CK2α was lowered by a fac-
tor of 3 in comparison to free CK2α and hence, the influ-
ence of the linkage to the transport unit of autodisplay 
had only a moderate effect on substrate conversion.
Conclusion
Autodisplay of CK2 subunits clearly results in CK2 activ-
ity. Surface-displayed CK2α and CK2β assemble on the 
cell surface to an active tetrameric holoenzyme. The 
whole-cell CK2 autodisplay assay is suitable for inhibi-
tion studies as demonstrated with the two selective CK2 
inhibitors TBB and Silmitasertib. Furthermore, it can be 
used to determine quantitative CK2 inhibition data such 
as IC50 values. So far we could not detect any drawbacks 
in replacing the purified enzyme by the surface-displayed 
CK2 for in vitro assays. In fact, the easy and quick avail-
ability of CK2 activity avoids a laborious purification pro-
cedure and makes the CK2 autodisplay assay a valuable 
tool in early drug discovery and development.
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